Cyclacel Pharmaceuticals, Inc.

[On Demand]
Search General Info
Search Education
Search Partnering Companies
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP) is a biopharmaceutical company developing innovative therapies that target various phases of cell cycle control for the treatment of cancer and other serious diseases.

Our strategy is to build a diversified portfolio of novel drug candidates to address areas of high unmet medical needs.
Ticker:
CYCC; CYCCP
Exchange:
NASDAQ
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
New Jersey
Company HQ Country:
United States
Year Founded:
1997
Main Therapeutic Focus:
Lead Product in Development:
Fadraciclib
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
President & CEO
Cyclacel Pharmaceuticals, Inc